Skip to main content
. 2007 Feb 7;1:205–213.

Table 1.

Serum copper and ceruloplasmin in controls and AD patients.

AD patients (n = 25) Controls (n = 25) test t
Serum Copper (μmol/L) 18 (6) 13.2 (2.2) p < 0.001
Ceruloplasmin (mg/dL) 27.9 (6.2) 26.5 (4.3) p = 0.369
Copper bound to ceruloplasmin (μmol/L) 13.1 (2.9) 12.5 (0.4) p = 0.369
Non-ceruloplsmin-copper (NCC) (μmol/L) 4.9 (5.6) 0.7 (1.9) p = 0.001

Data are presented as means (SD). Significant at the p = 0.05 level.